Press

¿Fin del Alzheimer?

¿Fin del Alzheimer?

Una empresa vallisoletana ha desarrollado un test capaz de detectar quién puede padecer alzhéimer en diez minutos mediante la apolipoproteína E4. Se presenta como el mejor medidor después de la edad y supondría un gran avance al poder detectar a edades tempranas el riesgo de sufrir la enfermedad

Biocross presents at Bio-Europe 2016

Biocross presents at Bio-Europe 2016

Biocross S.L., a biotechnology company focused on the development of innovative technologies for the diagnosis of Alzheimer’s disease and the identification of at-risk individuals, today announced that their Chief Executive Officer Matt Mittino will present the company’s projects at BIO-Europe 2016, the 22nd Annual International Partnering Conference, to be held Cologne, Germany from November 7–9, 2016.

Biospain 2016 – Company Presentation

Biospain 2016 – Company Presentation

Biospain has become the main scientific, social, commercial, and industrial meeting point of the biotechnological sector and the primary platform for the international presentation of advances in Spanish biotechnology.

Avda. Francisco Vallés, 8
47151 Boecillo (Valladolid) - Spain

+34 983 54 98 96